Epigenetics and microRNAs combine to modulate the MDM2/p53 axis in myeloma
- PMID: 20951939
- DOI: 10.1016/j.ccr.2010.10.004
Epigenetics and microRNAs combine to modulate the MDM2/p53 axis in myeloma
Abstract
Avoiding the inhibitory effects of p53 on cell growth is important for tumor progression. In this issue of Cancer Cell, Picchiorri et al. describe epigenetic silencing of MDM2-targeting microRNAs in multiple myeloma (MM), which generally appears to have intact p53 function. This provides the rationale for microRNA-targeted therapy for MM.
Copyright © 2010 Elsevier Inc. All rights reserved.
Comment on
-
RETRACTED: Downregulation of p53-inducible microRNAs 192, 194, and 215 impairs the p53/MDM2 autoregulatory loop in multiple myeloma development.Cancer Cell. 2010 Oct 19;18(4):367-81. doi: 10.1016/j.ccr.2010.09.005. Cancer Cell. 2010. Retraction in: Cancer Cell. 2022 Nov 14;40(11):1441. doi: 10.1016/j.ccell.2022.10.006. PMID: 20951946 Free PMC article. Retracted.
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
